Cupp E W, Bernardo M J, Kiszewski A E, Collins R C, Taylor H R, Aziz M A, Greene B M
Science. 1986 Feb 14;231(4739):740-2. doi: 10.1126/science.3753801.
Ivermectin, given to onchocerciasis patients as a single oral dose of 200 micrograms per kilogram of body weight, substantially reduced the uptake of Onchocerca volvulus microfilariae by Simulium yahense, an efficient black fly vector of the parasite in the tropical rain forests of West Africa. Three months after treatment, patients given ivermectin infected flies at a significantly lower rate than those who had received diethylcarbamazine or placebo, thereby reducing the number of developing larvae in the vector population. This diminished rate of infectiousness was also evident 6 months after treatment. These results strongly suggest that ivermectin could be effective in interrupting transmission of Onchocerca volvulus for epidemiologically important periods of time.
伊维菌素以每公斤体重200微克的单次口服剂量给予盘尾丝虫病患者,可显著降低雅氏蚋对盘尾丝虫微丝蚴的摄取,雅氏蚋是这种寄生虫在西非热带雨林中的一种高效黑蝇传播媒介。治疗三个月后,接受伊维菌素治疗的患者感染苍蝇的比率明显低于接受乙胺嗪或安慰剂的患者,从而减少了传播媒介种群中发育幼虫的数量。这种传染性降低的情况在治疗六个月后也很明显。这些结果有力地表明,在流行病学重要时间段内,伊维菌素可能有效地阻断盘尾丝虫的传播。